Company Abingdon Health Plc

Equities

ABDX

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

Market Closed - London S.E. Other stock markets 11:35:20 2024-04-24 am EDT			5-day change	1st Jan Change
10.5 ^GBX	0.00%		0.00%	-4.55%

Mar. 25	Peel Hunt's RetailBook raises GBP2.5 million	AN
Mar. 25	Abingdon Health Completes Design Freeze for STD Self-Tests	MT

Abingdon Health plc is a lateral flow contract development and manufacturing organization (CDMO). The Company develops, manufactures, and distributes diagnostic devices and provides consultancy services to businesses in the diagnostics sector. Its segments include Product sales, Contract manufacturing, and Contract development. Its customer base across industry sectors includes clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available.

Number of employees: 84

GBP in Million	2022	Weight	2023	Weight	Delta
Contract Development 56.9 %	1	44.0 %	2	56.9 %	+84.67%
Contract Manufacturing 26.2 %	1	39.6 %	1	26.2 %	-5.78%
Pocket Diagnostic Products and Other Tests 10.3 %	0	16.4 %	0	10.3 %	-10.11%
Regulatory 6.6 %	-	-	0	6.6 %	-

GBP in Million	2022	Weight	2023	Weight	Delta
United Kingdom 32.3 %	1	50.0 %	1	32.3 %	-7.76%
Europe (excluding Belgium) 29.1 %	0	11.8 %	1	29.1 %	+252.99%
United States & Canada 21.3 %	0	6.4 %	1	21.3 %	+373.08%
Belgium 11.8 %	1	26.0 %	0	11.8 %	-35.09%
Rest of the World 5.4 %	-	-	0	5.4 %	-

Managers	Title	Age	Since
Chris Yates FOU	Founder	50	08-01-15
Christopher William Hand FOU	Founder	63	08-01-15
Andrew Feather DFI	Director of Finance/CFO	-	23-10-23
Melanie Ross DFI	Director of Finance/CFO	45	21-01-25
Mark Jones COO	Chief Operating Officer	-	20-03-31
Nina Garrett CTO	Chief Tech/Sci/R&D Officer	-	19-10-31

Members of the board	Title	Age	Since
Christopher William Hand FOU	Founder	63	08-01-15
Mary Tavener BRD	Director/Board Member	62	20-10-25
Chris Yates FOU	Founder	50	08-01-15
Melanie Ross DFI	Director of Finance/CFO	45	21-01-25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	121,716,822	50,687,468 ( 41.64 %)	0	41.64 %

Name	Equities	%	Valuation
Mercia Fund Management Ltd. 14.85 %	18,071,000	14.85 %	2 M p
Christopher William Hand 10.83 %	13,178,467	10.83 %	2 M p
Hargreaves Lansdown Asset Management Ltd. 8.572 %	10,433,000	8.572 %	1 M p
Chris Yates 6.481 %	7,888,844	6.481 %	921 811 p
Catenalucis LLC 6.234 %	7,588,000	6.234 %	886 658 p
Thornapple LLP 5.452 %	6,636,000	5.452 %	775 417 p
JARVIS SECURITIES PLC 3.958 %	4,817,000	3.958 %	562 866 p
Touchstone Innovations Investment Management Ltd. 3.422 %	4,165,000	3.422 %	486 680 p
Unicorn Asset Management Ltd. 1.584 %	1,927,750	1.584 %	225 258 p
Hygea VCT Plc (Private Equity) 0.0637 %	77,551	0.0637 %	9 062 p

Abingdon Health Plc

York Biotech Campus Sand Hutton

YO41 1LZ, York

+44 19 0440 6050

http://www.abingdonhealth.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
ABINGDON HEALTH PLC	-4.55%	40.22M
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-11.57%	7.4B
DIASORIN S.P.A.	+2.98%	5.47B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.98%	4.51B
LANTHEUS HOLDINGS, INC.	+5.18%	4.42B
10X GENOMICS, INC.	-50.82%	3.29B
ANDON HEALTH CO., LTD.	+11.23%	2.66B
VITROLIFE AB	-16.38%	2.07B
MYRIAD GENETICS, INC.	-2.66%	1.68B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-10.84%	1.66B

Diagnostic & Testing Substances